Richard Delarue

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont et al. · The Lancet Oncology · 2011 · 545 citations

Medicine, Immunology, Oncology +15

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Matthew J. Maurer, Hervé Ghesquières, Jean‐Philippe Jais et al. · Journal of Clinical Oncology · 2014 · 410 citations · Full text

Medicine, Hematology, Oncology +17

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Christiane Copie‐Bergman, Peggy Cuillière-Dartigues, Maryse Baia et al. · Blood · 2015 · 254 citations · Full text

Life Sciences, Immunology, Oncology +12

[Research on a technic for measurement of spasticity].

G Tardieu, S Shentoub, Richard Delarue · PubMed · 1954 · 245 citations

Medicine, Neurology, Rehabilitation Medicine +9